STERIS plc (STE) Fair Value 2026

STE · Medical Devices ·

By CirclFi Research Team · Data from SEC EDGAR, FRED & GDELT

Quality Score

8.8 /10

32 fundamental signals · 11 models active

Value Trap Risk

SAFE (18/100)

Quick Summary — As of 2026-10-07, STERIS plc (STE) trades at $208.65, versus a $149.70 median fair value across its 11 active models — 28.3% below the current price. QOC: 8.8/10. Value Trap Risk: 18/100 (SAFE). 11/13 models active. Within that set, the Bayesian DCF component alone returns $195.49.

Key Facts

Ticker
STE
Price
$208.65
Quality Score
8.8/10
Value Trap Risk
18/100
Models Active
11/13
Last Updated
Strength: First Chicago suggests +43.1% upside with 66% confidence
Risk: Majority of models suggest overvaluation

Is STERIS plc (STE) Undervalued or Overvalued in 2026?

According to CirclFi’s 11-model valuation engine, STERIS plc (STE) appears overvalued as of : the median of 11 independent fair value estimates is $149.70, 28.3% below the current price of $208.65. Estimates range from $69.52 to $395.68. STE scores 8.8/10 on fundamental quality and 18/100 on value-trap risk.

For context, the median US equity CirclFi rates trades at an implied -20.1% versus its own 13-model consensus, across 3,777 rated companies as of 2026-10-07. STE’s -28.3% gap is wider than that market norm, and the Medical Devices sector median is -41.5%. Full market index →

This verdict compares price to intrinsic value only — it is not a buy or sell rating. For the decision case (bull vs bear arguments, risk factors, peers), read Should You Buy STERIS plc Stock in 2026? →

What Fair Value Does Each Model Give STE?

11 Intrinsic Value Models vs. Current Price ($208.65)

Core Models (Unlocked)
Model Fair Value Upside
Intrinsic · High Conviction
 $195.49 -6.3%
Intrinsic · High Conviction
 $69.52 -66.7%
Ensemble · Medium Conviction
 $149.70 -28.3%
Scenario · High Conviction
 $298.52 +43.1%
Unlock the Full Matrix

Access 7 additional models including EROIC Spread, Markov DDM, and more.

$2 / day

Billed monthly ($60/mo) or annually ($299/yr)

Unlock All 11 Models →

Cancel anytime · No contracts · Instant access

What Is STE's Fair Value Range?

Spread across 11 independent models · $69.52 to $395.68

CirclFi's 11 active models place STERIS plc (STE) between $69.52 and $395.68 per share, a spread of 218% of the median. The median of that range — $149.70 — is the fair value CirclFi publishes for STE, against a current price of $208.65.

Low · EPVHigh · Regime Cross
$69.52median $149.70$395.68
Where the range comes from
Most bearish modelEarnings Power Value (EPV)$69.52
Most bullish modelRegime Cross-Sectional$395.68
Model agreement2 bullish · 9 bearishwide

A band this wide is itself the finding. When independent methods land far apart, they are reading a business whose value depends heavily on which lens you apply — volatile earnings, heavy reinvestment, or an asset base that cash-flow and asset-based methods score differently. That disagreement is information: it says the choice of method matters more than usual for STE. Treat the median as one reading among several and compare the individual models below before acting.

Every figure above is one model's standalone output on STE, not a CirclFi price target. How each model works →

What Is STERIS plc (STE) Worth in 2026?

According to the CirclFi Deep Alpha Valuation Engine, STERIS plc's intrinsic value is estimated at $149.70. Trading at its current price of $208.65, the valuation engine raises significant caution: 9 of 11 models flag downside risk, projecting a median implied return of -28.3%. Model dispersion is worth noting: Regime Cross targets $395.68 (+89.6%), versus EPV at $69.52 (-66.7%). This +156.3% range highlights the importance of multi-model analysis rather than relying on any single methodology. Among models with highest confidence, Bayesian DCF, EPV, EROIC lean bearish — adding weight to the bearish side of the thesis.

What Do the Models Say About STE?

11 of 13 models are currently active for STE. Of these, 2 models suggest upside while 9 models suggest overvaluation. Taken together, their median fair value for STE is $149.70 — the figure CirclFi publishes as this stock's fair value. One component of that median, the Bayesian DCF, returns $195.49 on its own, implying -6.3% downside from the current price. See which stocks rank higher →

How Does STE Rank in Medical Devices?

Among 161 Medical Devices stocks, STE ranks #13 by Quality of Company score. CirclFi's QOC score of 8.8/10 evaluates 32 fundamental signals. A score of 8.8 places STE in the top tier.

See all Most Undervalued Medical Devices Stocks →

The Medical Devices sector introduces analytical considerations specific to biopharma enterprise businesses. For STERIS plc, metrics like FDA approval probability provide important context that general-purpose valuation models may underweight.

Is STE a Value Trap?

CirclFi's Value Trap algorithm assigns STE a score of 18/100 (SAFE). This indicates minimal risk. Fundamentals are healthy. The score cross-references apparent undervaluation against fundamental deterioration signals. Browse lowest value-trap stocks →

Multi-Model Methodology

11 of 13 models are active for STERIS plc. Broad coverage provides high confidence. Each model applies a fundamentally different valuation philosophy. See the complete methodology →

According to the CirclFi Quality of Company (QOC) framework, STERIS plc earns a quality score of 8.8/10. This robust rating reflects the company's standing across 32 fundamental signals spanning profitability, growth consistency, balance sheet strength, and capital allocation efficiency.

The gap between the most bullish and bearish model spans +156.3% — demonstrating why single-model analysis is dangerous. Browse all stocks with 13-model coverage →

Data Sources & Confidence

Every STE valuation is built from SEC EDGAR XBRL filings — 700+ standardized financial tags. Macroeconomic context from FRED calibrates discount rates, while GDELT news sentiment feeds into our Sentiment SOTP model. All pipelines run daily. Read the complete data methodology →

Across STE's 11 active models, average confidence is 58%. Moderate confidence indicates reasonable fit.

CirclFi's output is a research starting point, not a buy/sell signal. All data updates daily. Read the full methodology →

This analysis is produced by the CirclFi Valuation Engine using quantitative models applied to SEC EDGAR filings, public market feeds, and FRED macroeconomic indicators. It is not financial advice.

Read the full investment analysis: Should You Buy STERIS plc Stock in 2026? →

Bull case, bear case, risk factors & peer comparison — updated daily

Which Similar Medical Devices Stocks Should You Also Analyze?

11 related Medical Devices stocks with 13-model coverage

ABTAbbott LaboratoriesQOC 8.8TCMDTactile Systems Technology, Inc.QOC 8.8PENPenumbra, Inc.QOC 8.9ESMCEscalon Medical Corp.QOC 8.7BSXBoston Scientific CorporationQOC 8.9EWEdwards Lifesciences CorporationQOC 8.7PRCTPROCEPT BioRobotics CorporationQOC 6.9VYCOVycor Medical, Inc.QOC 6.0ALURAllurion Technologies Inc.QOC 4.8IRMDIRADIMED CORPORATIONQOC 9.8PODDInsulet CorporationQOC 9.6

Read investment analysis: ABT · TCMD · PEN · ESMC · BSX · EW · PRCT · VYCO · ALUR · IRMD · PODD

Which Other Stocks Have a Similar Quality Score to STE?

7 companies across all industries closest to STE’s Quality of Company score of 8.8/10.

EGANeGain CorporationQOC 8.8OSKOshkosh CorporationQOC 8.8RDYDr. Reddy's Laboratories LimitedQOC 8.8GRCThe Gorman-Rupp CompanyQOC 8.8HBANHuntington Bancshares IncorporatedQOC 8.8FDXFedEx CorporationQOC 8.8NVDANVIDIA CorporationQOC 10.0

Read investment analysis: EGAN · OSK · RDY · GRC · HBAN · FDX · NVDA

Where Does STE Sit in CirclFi's Medical Devices Rankings?

STE is ranked against every other Medical Devices stock CirclFi covers in each of these screens.

See all Medical Devices stocks ranked →

What Else Do Investors Ask About STERIS plc’s Valuation?

What is STERIS plc's intrinsic value in 2026?

CirclFi puts STERIS plc (STE)'s intrinsic value at $149.70 — the median of 11 independent model estimates as of 2026-10-07, ranging from $69.52 to $395.68. One component of that median, the Bayesian DCF, runs 10,000 Monte Carlo simulations with jump-diffusion and returns $195.49 on its own. The Quality of Company score is 8.8/10 across 32 fundamental signals. All models use SEC EDGAR filings updated daily. See our methodology page for how each model works.

Is STE overvalued or undervalued right now?

At $208.65, 2 of 11 active models suggest STE may be undervalued, while 9 indicate potential overvaluation. The median of all 11 fair value estimates is $149.70, 28.3% below the current price of $208.65 — a consensus view that STE is overvalued. The assessment depends on which methodology best fits STERIS plc's business model in Medical Devices.

What does a Quality of Company score of 8.8 mean for STE?

STERIS plc's QOC of 8.8/10 reflects 32 fundamental signals: profitability margins, revenue growth consistency, balance sheet leverage, free cash flow generation, and capital allocation efficiency. Scores above 7 indicate strong fundamentals and disciplined management.

How many valuation models does CirclFi run on STE?

CirclFi analyzes STE with 13 institutional-grade models daily: Bayesian DCF (Monte Carlo + jump-diffusion), EPV (Greenwald zero-growth), EROIC Spread (McKinsey reinvestment), First Chicago (3-scenario), Markov DDM (regime-switching), ML-RIV (machine learning residual income), Dynamic NAV (asset-based), PWERM (option-theoretic), Regime Cross-Sectional (relative), Sentiment SOTP (hybrid), CUCE Ensemble (meta-model), FTNN Topology (neural network), and RCMH-DCF (conditional regime). Currently 11 of 13 are active for this stock. Read the full methodology →

Which valuation models are most bullish and most bearish on STE?

Of the 11 models currently active on STE, Regime Cross-Sectional is the most bullish at $395.68 per share, and Earnings Power Value (EPV) is the most bearish at $69.52. CirclFi's published fair value for STE is the median of that range, $149.70, not either extreme. The gap between the two ends equals 218% of the median — a wide spread, meaning the methods genuinely disagree and the median should carry less weight. Browse stocks by value-trap risk →

Is STE a value trap in 2026?

STERIS plc's Value Trap score is 18/100 (SAFE). This low score indicates the current valuation is not artificially depressed by fundamental deterioration, suggesting genuine opportunity rather than a trap.

Cite this analysis — “According to CirclFi’s 11-model valuation engine, STERIS plc (STE) has a median fair value of $149.70 — 28.3% below the current price of $208.65 — as of 2026-10-07.” Source: circlfi.com/stock/STE/ · Methodology
Primary sources for this STE valuation
  • Financial statements: STERIS plc 10-K and 10-Q filings on SEC EDGAR (CIK 0001757898) — 700+ standardized XBRL tags, published by the U.S. Securities and Exchange Commission.
  • Discount-rate inputs: FRED, Federal Reserve Bank of St. Louis — risk-free rates, VIX, yield curve, inflation.
  • News sentiment: The GDELT Project — global media tone, input to the Sentiment SOTP model.
  • Model definitions: CirclFi methodology — the published specification for all 13 models, including the academic sources each one implements.

Market data for STE as of ; valuations recomputed .

You’ve done the research. Don’t stop at half the picture.

Stop collecting opinions. Let 11 mathematical frameworks give you clarity on STE.

Unlock All 11 Fair Values — $60/mo

Cancel anytime · Less than a cup of coffee · Instant access

7 models hidden for STE Unlock All 11 — $60/mo